Human biomarkers of rapid antidepressant effects

Biological Psychiatry

Volumn 73, Issue 12, 2013, Pages 1142-1155

  Zarate Jr , Carlos A ^a   Mathews, Daniel C ^a   Furey, Maura L ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Antidepressant; biomarker; cholinergic; depression; glutamate; ketamine; muscarinic; N methyl D aspartate; scopolamine; sleep deprivation

Indexed keywords

ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; FLUORODEOXYGLUCOSE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; INTERLEUKIN 6; KETAMINE; NEUROTROPHIC FACTOR; PLACEBO; SCOPOLAMINE; SEROTONIN 2A RECEPTOR; STEROID;

ELECTROENCEPHALOGRAM; EVOKED AUDITORY RESPONSE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; GENETICS; HUMAN; MAJOR DEPRESSION; MOOD DISORDER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SLEEP DEPRIVATION; TREATMENT RESPONSE;

ANTIDEPRESSIVE AGENTS; BIOLOGICAL MARKERS; GLUTAMIC ACID; HUMANS; MOOD DISORDERS; NEUROIMAGING; SLEEP DEPRIVATION; TIME FACTORS;

EID: 84878414188     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2012.11.031     Document Type: Review

References (101)

1. S. Moussavi, S. Chatterji, E. Verdes, A. Tandon, V. Patel, and B. Ustun Depression, chronic diseases, and decrements in health: results from the World Health Surveys Lancet 370 2007 851 858
2. H. Ledford Translational research: 4 ways to fix the clinical trial Nature 477 2011 526 528
3. A.J. Atkinson Jr, W.A. Colburn, V.G. DeGruttola, D.L. DeMets, G.J. Downing, and D.F. Hoth Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework Clin Pharmacol Ther 69 2001 89 95
4. A.F. Leuchter, I.A. Cook, S.P. Hamilton, K.L. Narr, A. Toga, and A.M. Hunter Biomarkers to predict antidepressant response Curr Psychiatry Rep 12 2010 553 562
5. F. Benedetti, and C. Colombo Sleep deprivation in mood disorders Neuropsychobiology 64 2011 141 151
6. J.C. Wu, and W.E. Bunney The biological basis of an antidepressant response to sleep deprivation and relapse: Review and hypothesis Am J Psychiatry 147 1990 14 21
7. B. Schilgen, and R. Tolle Partial sleep deprivation as therapy for depression Arch Gen Psychiatry 37 1980 267 271
8. J.J. Mann, D.A. Brent, and V. Arango The neurobiology and genetics of suicide and attempted suicide: A focus on the serotonergic system Neuropsychopharmacology 24 2001 467 477
9. D. Popa, C. Lena, V. Fabre, C. Prenat, J. Gingrich, and P. Escourrou Contribution of 5-HT2 receptor subtypes to sleep-wakefulness and respiratory control, and functional adaptations in knock-out mice lacking 5-HT2A receptors J Neurosci 25 2005 11231 11238
10. R.H. Kang, M.J. Choi, J.W. Paik, S.W. Hahn, and M.S. Lee Effect of serotonin receptor 2A gene polymorphism on mirtazapine response in major depression Int J Psychiatry Med 37 2007 315 329
11. F. Benedetti, B. Barbini, A. Bernasconi, M.C. Fulgosi, C. Colombo, and S. Dallaspezia Serotonin 5-HT2A receptor gene variants influence antidepressant response to repeated total sleep deprivation in bipolar depression Prog Neuropsychopharmacol Biol Psychiatry 32 2008 1863 1866
12. D.J. Nutt The role of dopamine and norepinephrine in depression and antidepressant treatment J Clin Psychiatry 67 2006 3 8
13. F. Benedetti, C. Colombo, A. Pirovano, E. Marino, and E. Smeraldi The catechol-O-methyltransferase Val(108/158)Met polymorphism affects antidepressant response to paroxetine in a naturalistic setting Psychopharmacology (Berl) 203 2009 155 160
14. S.J. Tsai, Y.T. Gau, C.J. Hong, Y.J. Liou, Y.W. Yu, and T.J. Chen Sexually dimorphic effect of catechol-O-methyltransferase val158met polymorphism on clinical response to fluoxetine in major depressive patients J Affect Disord 113 2009 183 187
15. F. Benedetti, and E. Smeraldi Neuroimaging and genetics of antidepressant response to sleep deprivation: Implications for drug development Curr Pharm Des 15 2009 2637 2649
16. J.C. Wu, J.C. Gillin, M.S. Buchsbaum, C. Schachat, L.A. Darnall, and D.B. Keator Sleep deprivation PET correlations of Hamilton symptom improvement ratings with changes in relative glucose metabolism in patients with depression J Affect Disord 107 2008 181 186
17. RM Benca, WH Obermeyer, RA Thisted, and JC Gillin Sleep and psychiatric disorders. A meta-analysis Arch Gen Psychiatry 49 1992 651 668 discussion 669-670
18. W.C. Duncan Jr, K.D. Pettigrew, and J.C. Gillin REM architecture changes in bipolar and unipolar depression Am J Psychiatry 136 1979 1424 1427
19. J.P. Doerr, V. Hirscher, D. Riemann, and U. Voderholzer [Disturbances of slow-wave sleep and psychiatric disorders] Nervenarzt 81 2010 347 354
20. W.C. Duncan Jr, J.C. Gillin, R.M. Post, R.H. Gerner, and T.A. Wehr Relationship between EEG sleep patterns and clinical improvement in depressed patients treated with sleep deprivation Biol Psychiatry 15 1980 879 889
21. C. Nissen, B. Feige, A. Konig, U. Voderholzer, M. Berger, and D. Riemann Delta sleep ratio as a predictor of sleep deprivation response in major depression J Psychiatr Res 35 2001 155 163
22. E.C. Landsness, M.R. Goldstein, M.J. Peterson, G. Tononi, and R.M. Benca Antidepressant effects of selective slow wave sleep deprivation in major depression: A high-density EEG investigation J Psychiatr Res 45 2011 1019 1026
23. A.E. Autry, and L.M. Monteggia Brain-derived neurotrophic factor and neuropsychiatric disorders Pharmacol Rev 64 2012 238 258
24. E. Castren, and T. Rantamaki The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity Dev Neurobiol 70 2010 289 297
25. A.R. Brunoni, M. Lopes, and F. Fregni A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: Implications for the role of neuroplasticity in depression Int J Neuropsychopharmacol 11 2008 1169 1180
26. C. Cirelli, and G. Tononi Gene expression in the brain across the sleep-waking cycle Brain Res 885 2000 303 321
27. Y. Gorgulu, and O. Caliyurt Rapid antidepressant effects of sleep deprivation therapy correlates with serum BDNF changes in major depression Brain Res Bull 80 2009 158 162
28. L. Ibrahim, W. Duncan, D.A. Luckenbaugh, P. Yuan, R. Machado-Vieira, and C.A. Zarate Jr Rapid antidepressant changes with sleep deprivation in major depressive disorder are associated with changes in vascular endothelial growth factor (VEGF): A pilot study Brain Res Bull 86 2011 129 133
29. G. Sanacora, G. Treccani, and M. Popoli Towards a glutamate hypothesis of depression: An emerging frontier of neuropsychopharmacology for mood disorders Neuropharmacology 62 2012 63 77
30. R.M. Berman, A. Cappiello, A. Anand, D.A. Oren, G.R. Heninger, and D.S. Charney Antidepressant effects of ketamine in depressed patients Biol Psychiatry 47 2000 351 354
31. C.A. Zarate Jr, J.B. Singh, P.J. Carlson, N.E. Brutsche, R. Ameli, and D.A. Luckenbaugh A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression Arch Gen Psychiatry 63 2006 856 864
32. C. Yuksel, and D. Ongur Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders Biol Psychiatry 68 2010 785 794
33. N. Michael, A. Erfurth, P. Ohrmann, V. Arolt, W. Heindel, and B. Pfleiderer Neurotrophic effects of electroconvulsive therapy: A proton magnetic resonance study of the left amygdalar region in patients with treatment-resistant depression Neuropsychopharmacology 28 2003 720 725
34. M. Aan Het Rot, C.A. Zarate Jr, D.S. Charney, and S.J. Mathew Ketamine for depression: where do we go from here? Biol Psychiatry 15 2012 15
35. D.C. Mathews, I.D. Henter, and C.A. Zarate Targeting the glutamatergic system to treat major depressive disorder: Rationale and progress to date Drugs 72 2012 1313 1333
36. M.F. Egan, M. Kojima, J.H. Callicott, T.E. Goldberg, B.S. Kolachana, and A. Bertolino The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function Cell 112 2003 257 269
37. R.J. Liu, F.S. Lee, X.Y. Li, F. Bambico, R.S. Duman, and G.K. Aghajanian Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex Biol Psychiatry 71 2012 996 1005
38. G. Laje, N. Lally, D. Mathews, N. Brutsche, A. Chemerinski, and N. Akula Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients Biol Psychiatry 72 2012 e27 e28
39. G. Salvadore, B.R. Cornwell, V. Colon-Rosario, R. Coppola, C. Grillon, and C.A. Zarate Jr Increased anterior cingulate cortical activity in response to fearful faces: A neurophysiological biomarker that predicts rapid antidepressant response to ketamine Biol Psychiatry 65 2009 289 295
40. J.C. Gillin, M. Buchsbaum, J. Wu, C. Clark, and W. Bunney Jr Sleep deprivation as a model experimental antidepressant treatment: Findings from functional brain imaging Depress Anxiety 14 2001 37 49
41. G. Salvadore, B.R. Cornwell, F. Sambataro, D. Latov, V. Colon-Rosario, and F. Carver Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine Neuropsychopharmacology 35 2010 1415 1422
42. D.A. Pizzagalli Frontocingulate dysfunction in depression: Toward biomarkers of treatment response Neuropsychopharmacology 36 2011 183 206
43. G. Hasler, J.W. van der Veen, T. Tumonis, N. Meyers, J. Shen, and W.C. Drevets Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy Arch Gen Psychiatry 64 2007 193 200
44. G. Salvadore, J.W. van der Veen, Y. Zhang, S. Marenco, R. Machado-Vieira, and J. Baumann An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression Int J Neuropsychopharmacol 1 2011 1 10
45. G. Rajkowska Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells Biol Psychiatry 48 2000 766 777
46. S.K. Esser, S.L. Hill, and G. Tononi Sleep homeostasis and cortical synchronization: I. Modeling the effects of synaptic strength on sleep slow waves Sleep 30 2007 1617 1630
47. B.A. Riedner, V.V. Vyazovskiy, R. Huber, M. Massimini, S. Esser, and M. Murphy Sleep homeostasis and cortical synchronization: III. A high-density EEG study of sleep slow waves in humans Sleep 30 2007 1643 1657
48. W.C. Duncan, S. Sarasso, F. Ferrarelli, J. Selter, B.A. Riedner, and N.S. Hejazi Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder Int J Neuropsychopharmacol 7 2012 1 11
49. W.C. Duncan Jr, J. Selter, N. Brutsche, S. Sarasso, and C.A. Zarate Jr Baseline delta sleep ratio predicts acute ketamine mood response in major depressive disorder [published online ahead of print August 4] J Affect Disord 2012
50. S.V. Argyropoulos, J.A. Hicks, J.R. Nash, C.J. Bell, A.S. Rich, and D.J. Nutt Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodone J Sleep Res 18 2009 342 348
51. C.L. Ehlers, J.W. Havstad, and D.J. Kupfer Estimation of the time course of slow-wave sleep over the night in depressed patients: Effects of clomipramine and clinical response Biol Psychiatry 39 1996 171 181
52. LL Davis, EC Frazier, BN Gaynes, MH Trivedi, SR Wisniewski, and M Fava Are depressed outpatients with and without a family history of substance use disorder different? A baseline analysis of the STAR*D cohort J Clin Psychiatry 68 2007 1931 1938
53. G.E. Tsai, P. Ragan, R. Chang, S. Chen, V.M. Linnoila, and J.T. Coyle Increased glutamatergic neurotransmission and oxidative stress after alcohol withdrawal Am J Psychiatry 155 1998 726 732
54. C. Allgaier Ethanol sensitivity of NMDA receptors Neurochem Int 41 2002 377 382
55. I.L. Petrakis, D. Limoncelli, R. Gueorguieva, P. Jatlow, N.N. Boutros, and L. Trevisan Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism Am J Psychiatry 161 2004 1776 1782
56. L.E. Phelps, N. Brutsche, J.R. Moral, D.A. Luckenbaugh, H.K. Manji, and C.A. Zarate Jr Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist Biol Psychiatry 65 2009 181 184
57. N. Diazgranados, L. Ibrahim, N.E. Brutsche, A. Newberg, P. Kronstein, and S. Khalife A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression Arch Gen Psychiatry 67 2010 793 802
58. C.A. Zarate Jr, N.E. Brutsche, L. Ibrahim, J. Franco-Chaves, N. Diazgranados, and A. Cravchik Replication of ketamine's antidepressant efficacy in bipolar depression: A randomized controlled add-on trial Biol Psychiatry 71 2012 939 946
59. G. Schumann, M. Johann, J. Frank, U. Preuss, N. Dahmen, and M. Laucht Systematic analysis of glutamatergic neurotransmission genes in alcohol dependence and adolescent risky drinking behavior Arch Gen Psychiatry 65 2008 826 838
60. D.S. Janowsky, M.K. el-Yousef, J.M. Davis, B. Hubbard, and H.J. Sekerke Cholinergic reversal of manic symptoms Lancet 1 1972 1236 1237
61. M.L. Furey, and W.C. Drevets Antidepressant efficacy of the antimuscarinic drug scopolamine: A randomized, placebo-controlled clinical trial Arch Gen Psychiatry 63 2006 1121 1129
62. W.C. Drevets, C.A Zarate Jr, and M.L Furey Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: A review [published online ahead of print November 28] Biol Psychiatry 2012
63. J.C. Wang, A.L. Hinrichs, H. Stock, J. Budde, R. Allen, and S. Bertelsen Evidence of common and specific genetic effects: Association of the muscarinic acetylcholine receptor M2 (CHRM2) gene with alcohol dependence and major depressive syndrome Hum Mol Genet 13 2004 1903 1911
64. D.M. Cannon, R.E. Carson, A.C. Nugent, W.C. Eckelman, D.O. Kiesewetter, and J. Williams Reduced muscarinic type 2 receptor binding in subjects with bipolar disorder Arch Gen Psychiatry 63 2006 741 747
65. D.M. Cannon, J.K. Klaver, S.K. Gandhi, G. Solorio, S.A. Peck, and K. Erickson Genetic variation in cholinergic muscarinic-2 receptor gene modulates M2 receptor binding in vivo and accounts for reduced binding in bipolar disorder Mol Psychiatry 16 2011 407 418
66. M.E. Hasselmo, and M. Sarter Modes and models of forebrain cholinergic neuromodulation of cognition Neuropsychopharmacology 36 2011 52 73
67. M.L. Furey The prominent role of stimulus processing: Cholinergic function and dysfunction in cognition Curr Opin Neurol 24 2011 364 370
68. J.M. Leppanen Emotional information processing in mood disorders: A review of behavioral and neuroimaging findings Curr Opin Psychiatry 19 2006 34 39
69. Furey ML, Drevets WC, Hoffman EM, Frankel E, Speer AM, Zarate CA Jr (in press): Pre-treatment neural activity in visual cortex during emotional processing predicts treatment response to scopolamine in major depressive disorder. Arch Gen Psychiatry.
70. Furey ML, Drevets WC, Khana A, Zarate CA Jr (2012): Differences in response to implicit emotional faces in anterior cingulate cortex predict antidepressant response to scopolamine in major depressive disorder. Biol Psychiatry 71:293S
71. N. Sitaram, J.I. Nurnberger Jr, E.S. Gershon, and J.C. Gillin Cholinergic regulation of mood and REM sleep: Potential model and marker of vulnerability to affective disorder Am J Psychiatry 139 1982 571 576
72. M.L. Furey, A. Khanna, E.M. Hoffman, and W.C. Drevets Scopolamine produces larger antidepressant and antianxiety effects in women than in men Neuropsychopharmacology 35 2010 2479 2488
73. M.L. Furey, A.C. Nugent, A.M. Speer, D.A. Luckenbaugh, E.M. Hoffman, and E. Frankel Baseline mood-state measures as predictors of antidepressant response to scopolamine Psychiatry Res 196 2012 62 67
74. R. Puri, M. Duong, K. Uno, Y. Kataoka, and S.J. Nicholls The emerging role of plasma lipidomics in cardiovascular drug discovery Expert Opin Drug Discov 7 2012 63 72
75. C.P. Clark, and S. Golshan Polysomnography and criteria for the antidepressant response to sleep deprivation J Affect Disord 101 2007 195 200
76. P. Danos, S. Kasper, H.P. Scholl, J. Kaiser, S. Ruhrmann, and G. Hoflich Clinical response to sleep deprivation and auditory-evoked potentials - preliminary results Pharmacopsychiatry 27 1994 70 71
77. D. Ebert, H. Feistel, and A. Barocka Effects of sleep deprivation on the limbic system and the frontal lobes in affective disorders: A study with Tc-99m-HMPAO SPECT Psychiatry Res 40 1991 247 251
78. S. Volk, S.H. Kaendler, R. Weber, K. Georgi, F. Maul, and A. Hertel Evaluation of the effects of total sleep deprivation on cerebral blood flow using single photon emission computerized tomography Acta Psychiatr Scand 86 1992 478 483
79. D. Ebert, H. Feistel, A. Barocka, and W. Kaschka Increased limbic blood flow and total sleep deprivation in major depression with melancholia Psychiatry Res 55 1994 101 109
80. D. Ebert, H. Feistel, W. Kaschka, A. Barocka, and A. Pirner Single photon emission computerized tomography assessment of cerebral dopamine D2 receptor blockade in depression before and after sleep deprivation - preliminary results Biol Psychiatry 35 1994 880 885
81. S.A. Volk, S.H. Kaendler, A. Hertel, F.D. Maul, R. Manoocheri, and R. Weber Can response to partial sleep deprivation in depressed patients be predicted by regional changes of cerebral blood flow? Psychiatry Res 75 1997 67 74
82. V.A. Holthoff, B. Beuthien-Baumann, U. Pietrzyk, J. Pinkert, L. Oehme, W.G. Franke, and O. Bach [Changes in regional cerebral perfusion in depression. SPECT monitoring of response to treatment] Nervenarzt 70 1999 620 626
83. J.C. Wu, J.C. Gillin, M.S. Buchsbaum, T. Hershey, J.C. Johnson, and W.E. Bunney Jr Effect of sleep deprivation on brain metabolism of depressed patients Am J Psychiatry 149 1992 538 543
84. G.S. Smith, C.F. Reynolds 3rd, B. Pollock, S. Derbyshire, E. Nofzinger, and M.A. Dew Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression Am J Psychiatry 156 1999 683 689
85. J. Wu, M.S. Buchsbaum, J.C. Gillin, C. Tang, S. Cadwell, and M. Wiegand Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex Am J Psychiatry 156 1999 1149 1158
86. G.S. Smith, C.F. Reynolds 3rd, P.R. Houck, M.A. Dew, Y. Ma, and B.H. Mulsant Glucose metabolic response to total sleep deprivation, recovery sleep, and acute antidepressant treatment as functional neuroanatomic correlates of treatment outcome in geriatric depression Am J Geriatr Psychiatry 10 2002 561 567
87. C.P. Clark, G.G. Brown, S.L. Archibald, C. Fennema-Notestine, D.R. Braun, and L.S. Thomas Does amygdalar perfusion correlate with antidepressant response to partial sleep deprivation in major depression? Psychiatry Res 146 2006 43 51
88. F. Benedetti, A. Bernasconi, V. Blasi, M. Cadioli, C. Colombo, and A. Falini Neural and genetic correlates of antidepressant response to sleep deprivation: A functional magnetic resonance imaging study of moral valence decision in bipolar depression Arch Gen Psychiatry 64 2007 179 187
89. H. Murck, M.I. Schubert, D. Schmid, P. Schussler, A. Steiger, and D.P. Auer The glutamatergic system and its relation to the clinical effect of therapeutic-sleep deprivation in depression - an MR spectroscopy study J Psychiatr Res 43 2009 175 180
90. F. Benedetti, G. Calabrese, A. Bernasconi, M. Cadioli, C. Colombo, and S. Dallaspezia Spectroscopic correlates of antidepressant response to sleep deprivation and light therapy: A 3.0 Tesla study of bipolar depression Psychiatry Res 173 2009 238 242
91. F. Benedetti, A. Serretti, C. Colombo, E. Campori, B. Barbini, and D. di Bella Influence of a functional polymorphism within the promoter of the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression Am J Psychiatry 156 1999 1450 1452
92. T.C. Baghai, C. Schule, P. Zwanzger, P. Zill, R. Ella, and D. Eser No influence of a functional polymorphism within the serotonin transporter gene on partial sleep deprivation in major depression World J Biol Psychiatry 4 2003 111 114
93. F. Benedetti, C. Colombo, A. Serretti, C. Lorenzi, A. Pontiggia, and B. Barbini Antidepressant effects of light therapy combined with sleep deprivation are influenced by a functional polymorphism within the promoter of the serotonin transporter gene Biol Psychiatry 54 2003 687 692
94. F. Benedetti, S. Dallaspezia, C. Lorenzi, A. Pirovano, D. Radaelli, and C. Locatelli Gene-gene interaction of glycogen synthase kinase 3-beta and serotonin transporter on human antidepressant response to sleep deprivation J Affect Disord 136 2012 514 519
95. F. Benedetti, B. Barbini, A. Bernasconi, M.C. Fulgosi, S. Dallaspezia, and C. Gavinelli Acute antidepressant response to sleep deprivation combined with light therapy is influenced by the catechol-O-methyltransferase Val(108/158)Met polymorphism J Affect Disord 121 2010 68 72
96. F. Benedetti, A. Lucca, F. Brambilla, C. Colombo, and E. Smeraldi Interleukine-6 serum levels correlate with response to antidepressant sleep deprivation and sleep phase advance Prog Neuropsychopharmacol Biol Psychiatry 26 2002 1167 1170
97. C. Schule, F. Di Michele, T. Baghai, E. Romeo, G. Bernardi, and P. Zwanzger Neuroactive steroids in responders and nonresponders to sleep deprivation Ann N Y Acad Sci 1032 2004 216 223
98. H. Murck, M. Uhr, M. Ziegenbein, H. Kunzel, K. Held, and I.A. Antonijevic Renin-angiotensin-aldosterone system, HPA-axis and sleep-EEG changes in unmedicated patients with depression after total sleep deprivation Pharmacopsychiatry 39 2006 23 29
99. B.R. Cornwell, G. Salvadore, M. Furey, C.A. Marquardt, N. Brutsche, and C. Grillon Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression Biol Psychiatry 72 2012 555 561
100. C.A.J. Zarate, N. Brutsche, G. Laje, D.A. Luckenbaugh, S.L. Venkata, and A. Ramamoorthy Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression Biol Psychiatry 72 2012 331 338
101. R. Machado-Vieira, P. Yuan, N. Brutsche, N. DiazGranados, D.A. Luckenbaugh, and C.A. Zarate Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-D-aspartate antagonist J Clin Psychiatry 70 2009 1662 1666